Streetbeat News

Regulatory

ARKB

GBTC

IBIT

Bitcoin spot ETFs saw significant inflows on March 27, with a total of $243 million, highlighting investor interest in cryptocurrency-based investment vehicles. BlackRock's iShares Bitcoin Trust (IBIT) led with $323 million in inflows, while Grayscale's Bitcoin Investment Trust (GBTC) experienced $299 million in outflows. Ark Invest's ARK Innovation ETF (ARKB) also saw a $200 million inflow. The industry is also closely watching the race for a spot Ethereum ETF in the U.S., with Fidelity Digital Assets filing for an ETF that includes a staking feature, despite skepticism from analysts about approval.

Portfolio Pulse from Murtuza Merchant

March 28, 2024 | 1:35 pm

BLZE

Backblaze, Inc. (NASDAQ:BLZE) announced it has earned inclusion in StateRAMP's Progressing Snapshot and the TX-RAMP Provisional programs, standardizing security requirements for SLED institutions. This achievement enhances Backblaze's security profile, making its storage solutions more accessible to a wider public sector, including those in Texas requiring TX-RAMP for procurement.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 1:06 pm

GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) announced its Chief Scientific Officer will present data on GEO-CM04S1, a next-generation Covid-19 vaccine, at the 24th Annual World Vaccine Congress in April 2024. GEO-CM04S1, based on GeoVax's MVA viral vector platform, is designed to induce broad immune responses and is currently being evaluated in three Phase 2 clinical trials targeting both primary vaccination and booster doses in various patient groups.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 1:06 pm

BLK

NKLA

NVDA

TSLA

The crypto market cap surpasses $2.6 trillion, driven by Dogecoin's spike and BlackRock's successful Bitcoin ETF. In US markets, Nvidia is removed from Piper Sandler's model portfolio, and the S&P 500 hits a new record. Biden's comprehensive policy for federal AI use is unveiled, amid various political and economic developments globally. In tech, significant investments in AI and lithium signal industry confidence. The electric vehicle sector sees mixed fortunes, with Tesla adjusting to Mexico's EV charging rules and Nikola launching a hydrogen fueling station.

Portfolio Pulse from Akanksha Bakshi

March 28, 2024 | 12:49 pm

RSLS

ReShape Lifesciences' stock is trading higher following the company's announcement of receiving a notice of allowance for a new US patent concerning its intragastric balloon system.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:49 pm

AON

AXAHF

The collapse of Baltimore's Francis Scott Key Bridge, caused by a collision with a Singapore-flagged container ship, could lead to an unprecedented insurance payout of up to $4 billion, surpassing the Costa Concordia disaster's $1.5 billion. AXA SA (AXAHF) is the lead reinsurer, with Aon PLC (AON) and Chubb Ltd (CB) also implicated as the insurance broker and involved insurer, respectively. The final payout will depend on factors like port closure duration and business interruption coverage.

Portfolio Pulse from Benzinga Neuro

March 28, 2024 | 12:42 pm

PTCT

PTC Therapeutics has submitted a Marketing Authorization Application (MAA) for Sepiapterin, a treatment for PKU, to the European Medicines Agency (EMA). This marks the first marketing authorization submission for Sepiapterin, with plans for additional global submissions in 2024.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:34 pm

GILD

The FDA has expanded the indication for Gilead Sciences' Vemlidy to include the treatment of chronic hepatitis B virus (HBV) infection in pediatric patients aged six years and older, weighing at least 25kg. This decision is based on the demonstrated efficacy and safety profile of Vemlidy in this patient group.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:33 pm

LEGH

MIRM

SNOW

Insider purchases at Snowflake, Legacy Housing, Mistras Group, and Mirum Pharmaceuticals signal confidence in these companies. Snowflake's CEO bought shares worth $5M, despite a recent downgrade. Legacy Housing and Mistras Group saw insider buys after reporting disappointing financial results. Mirum Pharmaceuticals' CFO purchased shares following FDA approval of its drug, Livmarli.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 12:33 pm

RSLS

ReShape Lifesciences has received a notice of allowance for an additional US patent related to its intragastric balloon system. This development could enhance the company's intellectual property portfolio and potentially its market position in obesity management solutions.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:31 pm